* Announces completion of enrollment for Phase 2b
Proof-Of-Concept clinical trial for SYN-004 (ribaxamase)
The post BRIEF-Synthetic Biologics announces completion of enrollment for Phase 2b appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Announces completion of enrollment for Phase 2b
Proof-Of-Concept clinical trial for SYN-004 (ribaxamase)
The post BRIEF-Synthetic Biologics announces completion of enrollment for Phase 2b appeared first on NASDAQ.